title: Suggestions for the management of factor VIII inhibitors.
authors.forename: M
authors.initials: M
authors.lastname: Rubinger
authors.forename: G E
authors.initials: GE
authors.lastname: Rivard
authors.forename: J
authors.initials: J
authors.lastname: Teitel
authors.forename: H
authors.initials: H
authors.lastname: Walker
mesh_terms: D002985:Clinical Protocols; D003663:Decision Trees; D019468:Disease Management; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007518:Isoantibodies / Q000097:blood*
chemical_list: D007518:Isoantibodies; D005169:Factor VIII